BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Vion Pharmaceuticals

About Vion

Vion Pharmaceuticals, Inc. is a biotechnology company that is developing novel agents for the treatment of cancer. We are evaluating two small molecule anticancer compounds in human clinical trials. Additional small molecule anticancer compounds are under development in preclinical studies.

 

 

CLINICAL TRIALS

Triapine® in Combination with Gemcitabine in Patients with Pancreatic Cancer

CLORETAZINE -- VNP40101M for Patients with Acute Myelogenous Leukemia or High-Risk Myelodysplasia

 

 

More on Vion Pharmaceuticals

Home page

Key Statistics for Vion

Basic Chart for Vion

Analyst Opinion

Analysts Estimates

News

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com